Asparaginase pharmacodynamics differ by formulation among children with newly diagnosed acute lymphoblastic leukemia (original) (raw)

References

1. Pui C-H, Evans WE . Acute lymphoblastic leukemia. N Engl J Med 1998; 339: 605–615.
   Article CAS Google Scholar
2. Silverman LB, Gelber RD, Dalton VK, Asselin BL, Barr RD, Clavell LA et al. Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. Blood 2001; 97: 1211–1218.
   Article CAS Google Scholar
3. Asselin BL, Kurtzberg J . Asparaginase. In: Pui C-H (ed) Treatment of Acute Leukemias. New Directions for Clinical Research. Totowa, NJ: Humana Press, 2003, pp 365–379.
   Google Scholar
4. Clavell LA, Gelber RD, Cohen HJ, Hitchcock-Bryan S, Cassady JR, Tarbell JN et al. Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia. N Engl J Med 1986; 315: 657–683.
   Article CAS Google Scholar
5. Capizzi RL, Bertino JR, Skeel RT, Creasey WA, Zanes R, Olayon C et al. L-asparaginase: clinical, biochemical, pharmacological, and immunological studies. Ann Intern Med 1971; 74: 893–901.
   Article CAS Google Scholar
6. Asselin BL, Ryan D, Frantz CN, Bernal SD, Leavitt P, Sallan SE et al. In vitro and in vivo killing of acute lymphoblastic leukemia cells by L-asparaginase. Cancer Res 1989; 49: 4363–4368.
   CAS PubMed Google Scholar
7. Asselin BL, Whitin JC, Coppola DJ, Rupp IP, Sallan SE, Cohen JH . Comparative pharmacokinetic studies of three asparaginase preparations. J Clin Oncol 1993; 11: 1780–1786.
   Article CAS Google Scholar
8. Peterson RG, Hanschumacher RE, Mitchell MS . Immunological responses to L-asparaginase. J Clin Invest 1971; 50: 1080–1090.
   Article CAS Google Scholar
9. Keating MJ, Holmes R, Lerner S, Ho DH . L-asparaginase and PEG asparaginase-past, present, and future. Leukemia Lymphoma 1993; 10: 153–157.
   Article Google Scholar
10. Oettgen HF, Stephenson PA, Schwartz MK, Leeper RD, Tallal L, Tan CC et al. Toxicity of E. coli L-asparaginase in man. Cancer 1970; 25: 253–278.
    Article CAS Google Scholar
11. Woo MH, Hak LJ, Storm MC, Sandlund JR, Ribeiro RC, Rivera GK et al. Anti-asparaginase antibodies following E. coli asparaginase therapy in pediatric acute lymphoblastic leukemia. Leukemia 1998; 12: 1527–1533.
    Article CAS Google Scholar
12. Killander D, Dohlwitz A, Engstedt L, Franzen S, Gahrton G, Gullbring B et al. Hypersensitivity reactions and antibody formation during L-asparaginase treatment of children and adults with acute leukemia. Cancer 1976; 37: 220–228.
    Article CAS Google Scholar
13. Kishi S, Griener J, Cheng C, Das S, Cook EH, Pei D et al. Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia. J Clin Oncol 2003; 21: 3084–3091.
    Article CAS Google Scholar
14. Wang B, Hak LJ, Relling MV, Pui C-H, Woo MH, Storm MC . Elisa to evaluate plasma anti-asparaginase IgG concentrations in patients with acute lymphoblastic leukemia. J Immunol Methods 2000; 239: 75–83.
    Article CAS Google Scholar
15. Lehmann EL . Nonparametrics: Statistical Methods Based on Ranks. San Francisco, CA: Holden-Day, Inc., 1975, 51pp.
    Google Scholar
16. Agresti A . An Introduction Categorical Data Analysis. New York, NY: John Wiley & Sons, Inc., 1996, 39pp.
    Google Scholar
17. Sallan SE, Hitchcock-Bryan S, Gelber R, Cassady JR, Frei E, Nathan DG . Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia. Cancer Res 1983; 43: 5601–5607.
    CAS PubMed Google Scholar
18. Ahlke E, Nowak-Gottl U, Schulze-Westhott P, Werber G, Borste H, Wurthwein G et al. Dose reduction of asparaginase under pharmacokinetic and pharmacodynamics control during induction therapy in children with acute lymphoblastic leukemia. Br J Haematol 1997; 96: 675–681.
    Article CAS Google Scholar
19. Boos J, Werber G, Ahlke E, Schulze-Westhoff P, Nowak-Gottl U, Wurthwein G et al. Monitoring of asparaginase activity and asparagines levels in children on different asparaginase preparations. Eur J Can 1996; 32A: 1544–1550.
    Article CAS Google Scholar
20. Abshire TC, Pollock BH, Billett AL, Bradley P, Buchanan GR . Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: a pediatric oncology group study. Blood 2000; 96: 1709–1715.
    CAS PubMed Google Scholar
21. Woo MH, Hak LJ, Storm MC, Sandlund JT, Ribeiro RC, Rivera GK et al. Hypersensitivity or development of antibodies of asparaginase do not impact treatment outcome of childhood acute lymphoblastic leukemia. J Clin Oncol 2000; 18: 1525–1532.
    Article CAS Google Scholar
22. Wang B, Relling MV, Storm MC, Woo MH, Ribeiro R, Pui C-H et al. Evaluation of immunologic crossreaction of antiasparaginase antibodies in acute lymphoblastic leukemia (ALL) and lymphoma patients. Leukemia 2003; 17: 1583–1588.
    Article CAS Google Scholar
23. Avramis VI, Sencer S, Periciou AP, Hather H, Bostrom BC, Cohen LJ et al. A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study. Blood 2002; 99: 1986–1994.
    Article CAS Google Scholar
24. Mitchell LG, Sutor AH, Andrew M . Hemostasis in childhood acute lymphoblastic leukemia: coagulopathy induced by disease and treatment. Semin Throm Hemostasis 1995; 21: 390–401.
    Article CAS Google Scholar
25. Nowak-Gottl U, Wermes C, Junker R, Koch HG, Schobess R, Fleischhack G et al. Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors. Blood 1999; 93: 1595–1599.
    CAS PubMed Google Scholar
26. Duval M, Suciu S, Ferster A, Rialland X, Nelken B, Lutz P et al. Comparison of _Escherichia coli-_asparaginase with _Erwinia-_asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer – Children's Leukemia Group phase 3 trial. Blood 2002; 99: 2734–2739.
    Article CAS Google Scholar
27. Nowak-Gottl U, Boos J, Wolff JEA, Erber G, Ahlke E, Pollmann H et al. Influence of two different E. coli asparaginase preparations on coagulation and fibrinolysis: a randomized trial. Fibrinolysis 1994; 8: 66.
    Article Google Scholar

Download references